Navigation Links
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
Date:3/12/2009

CALGARY, March 12 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) announced today that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours. The Principal Investigator is Dr. Miguel Villalona-Calero, Professor, Division of Hematology/Oncology and Department of Internal Medicine and Pharmacology at The Ohio State University Comprehensive Cancer Center.

"We are quite excited about this trial, since there are no known therapies that to date have effectively targeted K-RAS in cancer patients," said Dr. Villalona-Calero. "If this therapy works, this could substantially impact the outlook for our patients."

This trial (REO 016) is a single arm, single-stage, open-label, Phase 2 study of REOLYSIN(R) given intravenously with paclitaxel and carboplatin every 3 weeks. Patients will receive four to six cycles of paclitaxel and carboplatin in conjunction with REOLYSIN(R), at which time REOLYSIN(R) may be continued as a monotherapy. It is anticipated that up to 36 patients will be treated in this trial.

Eligible patients include those with metastatic or recurrent NSCLC with K-RAS or EGFR-activated tumours, who have not received chemotherapy treatment for their metastatic or recurrent disease. Patients must have demonstrated mutations in K-RAS or EGFR, or EGFR gene amplification in their tumours (metastatic or primary) in order to qualify for the trial.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
2. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
3. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
4. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
7. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
8. AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
9. AMA Foundation Announces Seed Grant Research Recipients
10. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
11. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... SPRINGS, Colo. , Aug. 22, 2014 /PRNewswire/ ... specializing in cannabis formulation-based drug development and related ... UFCM iCare,s third international medical cannabis conference taking ... Strasbourg, France , on October 22, ... with other stakeholders, such as researchers, health professionals, ...
(Date:8/22/2014)... , Aug. 22, 2014  WaferGen Bio-systems, Inc. ... public offering of units of common stock and warrants ... proceeds of $20 million, prior to deducting underwriting discounts ... The shares and warrants are immediately separable and will ... expected to begin trading on The NASDAQ Stock Market ...
(Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... ALTO, Calif., Nov. 3, 2011 Telik, Inc. (Nasdaq: ... million, or $0.05 per share, for the third quarter ended ... million, or $0.09 per share, for the comparable period in ... total operating costs and expenses were $2.9 million, compared with $4.7 ...
... Aoxing Pharmaceutical (NYSE Amex: AXN ) ... research, development, manufacturing and distribution of narcotic, pain-management, ... operating subsidiary in China, Hebei Aoxing Pharmaceutical Group ... million RMB (approximately $315,000) from the Industry and ...
Cached Medicine Technology:Telik Announces Third Quarter 2011 Financial Results 2Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China 2Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China 3
(Date:8/22/2014)... (PRWEB) August 23, 2014 Recently, Skmen.com, ... new collection of 2014 bohemian dresses in its online ... deeply discounted prices, up to 28% off. All the ... before August 31, 2014. , The company’s ... Skmen.com wants to show worldwide customers more the latest ...
(Date:8/22/2014)... MyWriters.com , an online source ... experts for marketers to help them drive traffic to ... of Shane Michaels, prompting an investigative review. , ... way knows that content is king when it comes ... “But even though content is extremely important, creating quality, ...
(Date:8/22/2014)... 2014 With the stage set for ... Store Expo - which will be held in Boston ... op-ed in its online opinion section, Podium. The ... is co-authored by Steven C. Anderson, IOM, CAE, president ... of the MCPHS University School of Pharmacy – Worcester/Manchester. ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The regional ... Toyota Indiana is on the grow again. ... jobs by summer 2016 to boost production of the ... bring Toyota Indiana’s overall investment to $4 billion. This ... America while providing additional flexibility to adjust its product ...
(Date:8/22/2014)... FRIDAY, Aug. 22, 2014 (HealthDay News) -- Many Americans know ... about the possibility of an outbreak in the United States, ... said they are worried that there will be a major ... that they or an immediate family member will get sick ... the latest Harvard School of Public Health poll. However, ...
Breaking Medicine News(10 mins):Health News:Cheap Bohemian Dresses Unveiled by Experienced Supplier Skmen.com 2Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2
... TUESDAY, Dec. 27 (HealthDay News) -- With all those parties, tempting ... your fitness program during the holidays. But doing so can ... on a healthful new year, according to Kara Smith, a fitness ... "Whether you,re at home for the holidays or traveling, it ...
... allergists, Robert Wood of the Johns Hopkins Children,s Center and ... clinicians to use caution when ordering allergy tests and to ... In an article, published in the January issue of ... increasingly popular diagnostic tool in recent years, and skin-prick testing, ...
... Dec. 24 (HealthDay News) -- Reindeer have lots to do ... to dragging heavy sleighs -- but despite all their frenzied ... without getting dangerously overheated, researchers have found. Now, Norwegian ... monitoring the brains of reindeer as they exercised on solid ...
... -- The holiday season can be especially meaningful for cancer ... stay healthy through this often hectic and stressful time. ... their ranks are growing. Many of these folks have long-term ... experts at the Fred Hutchinson Cancer Research Center pointed out ...
... Tuesday, December 27, 2011, Cleveland: Cleveland Clinic researchers Bruce Lamb, ... the American Association for the Advancement of Science (AAAS). ... upon AAAS members by their peers. , This year 539 ... their scientifically or socially distinguished efforts to advance science or ...
... U.S. and around the world will convene in Portland, Oregon ... America (LSA) this January. , Members of the news media ... The meeting is scheduled for January 5-8, 2012, at ... a forum for the presentation of cutting-edge research focused on ...
Cached Medicine News:Health News:Get a Head Start on 2012 Fitness Resolutions 2Health News:Memo to pediatricians: Allergy tests are no magic bullets for diagnosis 2Health News:Memo to pediatricians: Allergy tests are no magic bullets for diagnosis 3Health News:Study Shows How Busy Reindeer Keep Their Cool 2Health News:Cancer Survivors Should Take Steps to Keep Healthy During Holidays 2
... Vibratome comes standard with a square ... blocks are utilized for mounting specimens ... vice. The blocks are annodized ... can be reused. They are ...
This is a perfect tool for retrieving free floating sections from the Vibratome bath....
... an optional component available for Vibratome ... plugs into the back of all ... a selector switch. Once activated, ... initiating a sectioning sequence and reversing ...
... 900R is a modular peltier refrigeration system that ... It utilizes the Deluxe bath system as standard ... repeatable specimen orientation. The unit will chill ... degree centigrade to ambient temperature. It will ...
Medicine Products: